Carbon Nanotubes Reinforced Composites for Biomedical Applications

Figure 5

Tissue responses at one week after implantation [98, 110–112]. (a) MWCNTs powders, (b) 100% MWCNTs monolith, (c) MWCNTs/5% PCS, (d) MWCNTs/20% PCS, and (e) MWCNTs/25% PCS.

(a)

(b)

(c)

(d)

(e)